Loading...
Loading...
In a report published Thursday, Morgan Stanley analyst Andrew Schenker initiated coverage on
HumanaHUM with an Equal-Weight rating.
In the report, Morgan Stanley noted, “Medicare Advantage will be a long-term growth driver for HUM. Strong positioning in individual exchanges should lead to enrollment growth. However, funding gaps in 2014 and 2015 will pressure margins and force HUM to find incremental offsets. Significant investments in 2014 to prepare for exchanges and Medicaid weigh on earnings but are not expected to persist.”
Humana closed on Wednesday at $100.28.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in